4.4 Article

Cognitive impairments in breast cancer survivors treated with chemotherapy: a study based on event-related potentials

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

A perylene derivative regulates HIF-1α and Stat3 signaling pathways

Han Chen et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2014)

Review Oncology

Central nervous system toxicities of chemotherapeutic agents

Parvin F. Peddi et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2014)

Article Clinical Neurology

Neuropsychological Outcomes of Older Breast Cancer Survivors: Cognitive Features Ten or More Years After Chemotherapy

Torricia H. Yamada et al.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2014)

Article Psychology, Clinical

A Meta-Analysis of Cognitive Impairment Following Adult Cancer Chemotherapy

Oana C. Lindner et al.

NEUROPSYCHOLOGY (2014)

Article Neuroimaging

Chemotherapy-related cognitive dysfunction: current animal studies and future directions

R. Seigers et al.

BRAIN IMAGING AND BEHAVIOR (2013)

Article Oncology

Cognitive Complaints After Breast Cancer Treatments: Examining the Relationship With Neuropsychological Test Performance

Patricia A. Ganz et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)

Article Oncology

Global and focal brain volume in long-term breast cancer survivors exposed to adjuvant chemotherapy

Vincent Koppelmans et al.

BREAST CANCER RESEARCH AND TREATMENT (2012)

Article Neurosciences

Cerebral Hyporesponsiveness and Cognitive Impairment 10 Years After Chemotherapy for Breast Cancer

Michiel B. de Ruiter et al.

HUMAN BRAIN MAPPING (2011)

Article Clinical Neurology

The role of event-related potentials in cognitive decline in Alzheimer's disease

Chiou-Lian Lai et al.

CLINICAL NEUROPHYSIOLOGY (2010)

Article Clinical Neurology

Auditory P300 event-related potential in tobacco smokers

Figen Guney et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2009)

Article Oncology

Persistent neurocognitive problems after adjuvant chemotherapy for breast cancer

Baudewijntje P. C. Kreukels et al.

CLINICAL BREAST CANCER (2008)

Article Clinical Neurology

ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy

Baudewijntje P. C. Kreukels et al.

CLINICAL NEUROPHYSIOLOGY (2008)

Review Clinical Neurology

Updating p300: An integrative theory of P3a and P3b

John Polich

CLINICAL NEUROPHYSIOLOGY (2007)

Article Oncology

Cognitive-behavioral management of chemotherapy-related cognitive change

Robert J. Ferguson et al.

PSYCHO-ONCOLOGY (2007)

Article Oncology

Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients

Sanne B. Schagen et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)

Article Psychology, Biological

P300 as a clinical assay: rationale, evaluation, and findings

J Polich et al.

INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY (2000)

Article Oncology

Cognitive function in breast cancer patients receiving adjuvant chemotherapy

CB Brezden et al.

JOURNAL OF CLINICAL ONCOLOGY (2000)